AGIO
Agios·NASDAQ
--
--(--)
--
--(--)
AGIO Filings
Filing Date
Form Description
Form Type
2025-12-05
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-05 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-14 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-13
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form 144 - Report of proposed sale of securities
Ownership
2025-11-12 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-30
Agios Pharmaceuticals, Inc. (AGIO) Q3 2025 Earnings Call Transcript
Earnings Call
2025-10-30 · Earnings Call
Agios Pharmaceuticals, Inc. (AGIO) Q3 2025 Earnings Call Transcript
2025-10-30
Form 144 - Report of proposed sale of securities
Ownership
2025-10-30 · Ownership
Form 144 - Report of proposed sale of securities
2025-10-30
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-10-30 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-30
Form 8-K - Current report
Key Events
2025-10-30 · Key Events
Form 8-K - Current report
